Public Profile

Grifols Therapeutics, Inc.

Grifols Therapeutics, Inc., a leading global biotechnology company, is headquartered in the United States and operates extensively across Europe, Latin America, and Asia. Founded in 1909, Grifols has established itself in the biopharmaceutical industry, specialising in the development of innovative therapies derived from human plasma. The company’s core products include immunoglobulins, albumin, and clotting factors, which are essential for treating various medical conditions, including immune deficiencies and bleeding disorders. Grifols is renowned for its commitment to quality and safety, setting industry standards with its advanced manufacturing processes. With a strong market position, Grifols has achieved significant milestones, including the expansion of its global network of plasma collection centres. This strategic growth enhances its ability to deliver life-saving therapies to patients worldwide, solidifying its reputation as a trusted leader in the biopharmaceutical sector.

DitchCarbon Score

How does Grifols Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Grifols Therapeutics, Inc.'s score of 32 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Grifols Therapeutics, Inc.'s reported carbon emissions

Grifols Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented reduction initiatives or climate pledges that outline their commitments to reducing greenhouse gas emissions. In the context of the biopharmaceutical industry, companies are increasingly focusing on sustainability and climate action, but specific details regarding Grifols' commitments remain unspecified.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Grifols Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Grifols Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Grifols Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ADMA Biologics, Inc.

US
Health and social work services (85)
Updated 2 days ago

Octapharma

CH
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Biotest

DE
Health and social work services (85)
Updated 2 days ago

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Kedrion

IT
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers